The early stages of multiple sclerosis: new targets for the development of combinational drug therapies
No Thumbnail Available
File version
Author(s)
Cock, Ian
Cheesman, Matthew
Cheesman, Matthew
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
El-Baz, Ayman
Suri, Jasjit S
Date
2020
Size
File type(s)
Location
License
Abstract
This chapter examines the bacterial triggers of rheumatoid arthritis and how they may induce self-reactive antibody production. In so doing, this report highlights some targets for drug treatments aimed at blocking the early phases of multiple sclerosis before the more serious later phase events occur.
Journal Title
Conference Title
Book Title
Neurological Disorders and Imaging Physics, Volume 2
Edition
Volume
2
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Pharmaceutical sciences
Clinical sciences
Persistent link to this record
Citation
Cock, I; Cheesman, M, The early stages of multiple sclerosis: new targets for the development of combinational drug therapies, Neurological Disorders and Imaging Physics, Volume 2, 2020, 2, pp. 2-1-2-38